MAB1302
小鼠抗人IgG抗体，克隆HP6017，Fc
clone HP6017, Chemicon®, from mouse
别名:
Anti-CD32, Anti-CD32B, Anti-FCG2, Anti-FCGR2, Anti-FCGR2C, Anti-FcGRIIB, Anti-FcRII-c, Anti-FcgammaRIIb, Anti-IGFR2
产品名称
小鼠抗人IgG抗体，克隆HP6017，Fc, clone HP6017, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
secondary antibodies
clone
HP6017, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
radioimmunoassay: suitable
western blot: suitable
isotype
IgG2aκ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... FCGR2B(2213)
Application
使用经验证可用于ELISA、RIA &WB的小鼠抗人IgG抗体，克隆HP6017，Fc检测人IgG。
可用作人IgG Fc的捕获抗体和检测抗体（Papadea et al., 1985; Hamilton, et al., 1987）。
ELISA
放射免疫测定（RIA）
免疫印迹。
最佳工作稀释度必须由最终用户进行确定。
ELISA
放射免疫测定（RIA）
免疫印迹。
最佳工作稀释度必须由最终用户进行确定。
研究子类别
片段特异性二抗
片段特异性二抗
研究类别
二抗&对照抗体
二抗&对照抗体
Biochem/physiol Actions
人 IgG Fc 片段。ELISA特异性：（Hamilton et al.，1987）
人IgG亚类1 100%
人IgG 亚类2 100%
人IgG 亚类3 100%
人IgG亚类 4 100%
人IgG Pan 100%
人IgG Fc 100%
人IgG Fab .12%
等电聚焦： 平均pI8.0
人IgG亚类1 100%
人IgG 亚类2 100%
人IgG 亚类3 100%
人IgG亚类 4 100%
人IgG Pan 100%
人IgG Fc 100%
人IgG Fab .12%
等电聚焦： 平均pI8.0
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Immunogen
表位：Fc片段
Other Notes
替代品：CBL102
浓度：请参考批次特异性浓缩物的分析证书。
Physical form
形式：纯化
纯化的免疫球蛋白。 0.02 M PB，0.25 M NaCl，含0.1%叠氮化钠，pH=7.6中的液体。
Preparation Note
以未稀释的等分试样保存于2-8°C下12个月。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Gunnveig Grodeland et al.
Journal of immunology (Baltimore, Md. : 1950), 197(9), 3575-3585 (2016-09-28)
It has been difficult to translate promising results from DNA vaccination in mice to larger animals and humans. Previously, DNA vaccines encoding proteins that target Ag to MHC class II (MHC-II) molecules on APCs have been shown to induce rapid
Miguel Ángel Muñoz-Alía et al.
PLoS pathogens, 17(2), e1009283-e1009283 (2021-02-04)
The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for the treatment of metastatic neoplasia.
Kartik A Shah et al.
Biotechnology and bioengineering, 112(12), 2624-2629 (2015-06-03)
Monoclonal antibodies (mAbs) that bind and neutralize human pathogens have great therapeutic potential. Advances in automated screening and liquid handling have resulted in the ability to discover antigen-specific antibodies either directly from human blood or from various combinatorial libraries (phage
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持